When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ONCY - Oncolytics Bio launches mid-stage combination trial in breast cancer
Oncolytics Biotech Inc.
Oncolytics Biotech (NASDAQ:ONCY) announces a new investigator-sponsored triple-negative breast cancer (TNBC) study to be managed by Rutgers Cancer Institute of New Jersey.
More news on: Oncolytics Biotech Inc., Incyte Corporation, Healthcare stocks news,